Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renuva for Knee Fat Pad Impingement
NCT05880888Phase 1Completed
- Sponsor
- The Ohio State University
- Start
- Apr 2023
- Primary completion
- Jan 2024
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Renuva Allograft Adipose Matrix in fat pad syndrome, sponsored by The Ohio State University. Primary endpoints: Knee MRI measurements of fat pad thickness at 6 months, Knee MRI measurements of fat pad surface area at 6 months and 1 more. Started Apr 2023; status: completed.
02
Drugs
Renuva Allograft Adipose Matrix
03
Conditions
fat pad syndrome
Beyond the preview
Go deeper on NCT05880888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05880888.